-
Iran and the U.S. Were Set To Negotiate. Then Israel Attacked.From 🇺🇸 The Journal, published at 2025-06-13 21:22
U.S. officials planned to meet with an Iranian delegation this weekend to discuss curbs on Iran’s nuclear program. In a twist, those talks ended up as cover for a surprise Israeli attack that killed top Iranian officials and struck key nuclear sites. Now, Iran is retaliating. WSJ’s Michael R. Gordon lays out the U.S.’s diplomacy efforts in the Middle East and explains what to expect next. Annie Minoff hosts. Further Listening: - Why Israel and Hamas Could Be Headed Into a Forever War - A Deadly Drone Attack and Iran’s ‘Axis of Resistance’ Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
The Conservative Trying to Shift America Rightward... One Movie at a TimeFrom 🇺🇸 The Journal, published at 2025-06-12 20:29
Leonard Leo is a conservative lawyer and co-chairman of the Federalist Society who played a significant role in shifting the U.S. Supreme Court rightward. Now he is focusing his efforts on reshaping American culture through entertainment. He’s channeling funds towards high production value Christian and conservative television shows and films, including Amazon Prime’s hit "House of David.” WSJ’s Maggie Severns reports on how Leo is using a fund of more than $1 billion to back Hollywood blockbusters that push a more right-wing agenda. Jessica Mendoza hosts. Further Listening: -The Return of Religious Films to Hollywood -Ron Howard and Brian Grazer on Longevity in Hollywood Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Inside UnitedHealth’s Dramatic FalteringFrom 🇺🇸 The Journal, published at 2025-06-11 20:27
UnitedHealth is the largest healthcare company in the U.S. But over the last 18 months, a string of challenges, including several Justice Department probes, have tested the company. WSJ’s Anna Wilde Mathews and Christopher Weaver report on how the company rose to prominence, why its CEO is out, and how it has weathered the setbacks. Annie Minoff hosts. Further Listening: -Medicare, Inc. Part 1: How Insurers Make Billions From Medicare -Medicare, Inc. Part 2: Taxpayers Paid for Care Denied by Insurers Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Inside ICE’s Aggressive Approach to Arresting MigrantsFrom 🇺🇸 The Journal, published at 2025-06-10 20:57
To fulfill a key campaign promise, the Trump administration has been pushing ICE to arrest more migrants. WSJ’s Michelle Hackman explains how that’s led to more aggressive tactics and raids like the ones that unfolded in Los Angeles on Friday, sparking major protests. Jessica Mendoza hosts. Further Listening: - Deportations Could Upend This Parachute Factory - How Frog Embryos Landed a Scientist in ICE Detention - A New Phase in Trump’s Immigration Fight Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Are Trump and Musk Done for Good?From 🇺🇸 The Journal, published at 2025-06-09 20:29
The storybook bromance between President Donald Trump and Elon Musk seems to have come to an end. WSJ’s Rebecca Ballhaus unpacks what happened and what the stakes are for the two powerful men. Jessica Mendoza hosts. Further Listening: - Tesla Has a Problem: Elon Musk - Elon Musk’s Secret Conversations With Vladimir Putin - Inside USAID as Elon Musk and DOGE Ripped it Apart Sign up for WSJ’s free What’s News newsletter . Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Medicare, Inc. Part 2: Taxpayers Paid for Care Denied by InsurersFrom 🇺🇸 The Journal, published at 2025-06-07 16:00
Some of the sickest Medicare Advantage patients ran into problems getting end-of-life care. Ultimately many patients switched to traditional Medicare, costing taxpayers billions, according to an investigation by the Wall Street Journal. This is one of many Medicare Advantage practices that is now under government scrutiny. Both Congress and Medicare agency head Dr. Mehmet Oz are pushing for reforms to curb tactics that can boost federal payments to private insurers. The Department of Justice is also investigating major private insurance companies UnitedHealth, Aetna, Elevance Health and Humana. Jessica Mendoza discusses the investigations with WSJ’s Anna Wilde Mathews. Further Listening: -Medicare, Inc. Part 1: How Insurers Make Billions From Medicare -A Life-or-Death Insurance Denial Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Medicare, Inc. Part 1: How Insurers Make Billions From MedicareFrom 🇺🇸 The Journal, published at 2025-06-06 20:00
Medicare Advantage was designed to save the government money. But a Wall Street Journal investigation found that private insurers used the program to generate extra payments through questionable diagnoses. The investigation uncovered instances of potentially deadly illnesses like AIDS, where patients received no follow-up care, as well as diagnoses that were medically impossible. This happened in part when insurers sent nurse practitioners into Medicare Advantage recipients’ homes. Jessica Mendoza discusses the investigation with WSJ’s Christopher Weaver as well as a nurse who participated in the program. Further Listening: -A Life-or-Death Insurance Denial -Even Doctors Are Frustrated With Health Insurance Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Deportations Could Upend This Parachute FactoryFrom 🇺🇸 The Journal, published at 2025-06-05 20:11
A special immigration status helped Mills Manufacturing, which makes parachutes for the U.S. military, keep its workforce fully staffed. But last week, an order from the Supreme Court allowed the Trump Administration to revoke temporary protections for about 500,000 immigrants from Cuba, Venezuela, Haiti, and Nicaragua. WSJ’s Ruth Simon explains why companies like Mills are scrambling. Annie Minoff hosts. Further Listening: - A New Phase in Trump’s Immigration Fight - How Frog Embryos Landed a Scientist in ICE Detention Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
The Struggle to Get Aid Into GazaFrom 🇺🇸 The Journal, published at 2025-06-04 20:39
An Israeli-backed system meant to deliver aid and food into Gaza launched last week to scenes of chaos and violence. WSJ's Anat Peled breaks down the new system, and explains why getting aid to the region is difficult and dangerous. Jessica Mendoza hosts. Further Listening: - A Fragile Cease-Fire Deal in Gaza - The UN Agency Accused of Links to Hamas Learn more about your ad choices. Visit megaphone.fm/adchoices
-
The Everyday American Who Hustled for North KoreaFrom 🇺🇸 The Journal, published at 2025-06-03 20:40
Christina Chapman presented herself as just another influencer on TikTok. In reality, she operated a “laptop farm” that allowed North Koreans to take jobs as U.S. tech workers and scam more than 300 U.S. companies out of millions of dollars. WSJ’s Robert McMillan breaks down the scam and Chapman’s crucial role in it. Annie Minoff hosts. Further Listening: - North Korea's Propaganda Mastermind - Your New Hire May Be a North Korean Spy - Hack Me If You Can Sign up for WSJ’s free What’s News newsletter . Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Stop Making Cents: The End of the PennyFrom 🇺🇸 The Journal, published at 2025-06-02 20:00
Minting one penny costs the United States nearly four cents. After 233 years, the Treasury Department has decided to phase out the coin. This will mean that businesses will have to round cash transactions up or down, and some fear it could lead to inflation. We reminisce about the cultural significance of the one-cent coin with WSJ’s Oyin Adedoyin and discuss the pro-penny stance with an advocate. WSJ’s Jessica Mendoza hosts. Further Listening: - The Fight Over Your Credit Card Swipe - The Coronavirus Cash Crisis Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Ron Howard and Brian Grazer on Longevity in HollywoodFrom 🇺🇸 The Journal, published at 2025-06-01 16:00
Ron Howard and Brian Grazer are the Oscar winning director and producer behind some of Hollywood's most memorable movies like A Beautiful Mind, Apollo 13 and The Da Vinci Code. The duo, who co-founded Imagine Entertainment in 1985, sat down with WSJ's Ben Fritz at the Future of Everything Festival to talk about longevity in Hollywood, AI in movie production and the future of movies. Further Listening: - Why Hollywood Is Betting Big on ‘Wicked’ - With Great Power, Part 1: Origin Story Sign up for WSJ’s free What’s News newsletter. Photo: Uncredited Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Trump's Plan B After Trade Court SetbackFrom 🇺🇸 The Journal, published at 2025-05-30 19:56
This week, an obscure trade court dropped a bombshell ruling: President Trump did not have the authority to issue sweeping tariffs under a 1977 law. The government has appealed the court’s decision. WSJ’s James Fanelli and Gavin Bade dig into the ruling and what it could mean for the future of Trump’s trade agenda. Annie Minoff hosts. Further Listening: The Tariff Trade Off: Jobs vs. Higher Prices A Tariff Loophole Just Closed. What That Means for Online Shopping Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
NPR’s CEO on the Fight Over Public MediaFrom 🇺🇸 The Journal, published at 2025-05-29 20:00
In May, President Trump signed an executive order cutting off federal funding for public broadcasters, including NPR and PBS. In his order, Trump said “neither entity presents a fair, accurate or unbiased portrayal of current events to taxpaying citizens.” WSJ’s Joe Flint breaks down the decades-long fight over public media, and NPR’s CEO Katherine Maher explains why her network is challenging the Trump administration in court. Jessica Mendoza hosts. Further Listening: -For Millions of Student-Loan Borrowers, It's Time to Pay -Can the GOP Unite Around Trump's 'Big, Beautiful Bill'? Sign up for WSJ’s free What’s News newsletter . Learn more about your ad choices. Visit megaphone.fm/adchoices
-
For Millions of Student-Loan Borrowers It's Time to PayFrom 🇺🇸 The Journal, published at 2025-05-28 19:54
The Trump administration is starting to put millions of defaulted student-loan borrowers into collections and threatening to confiscate their wages, tax refunds and federal benefits. WSJ’s Oyin Adedoyin digs into what the restart could mean for borrowers and the economy. Annie Minoff hosts. Further Listening: -Biden’s New Plan to Cancel Student Debt -Breaking Down Student Debt Relief Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
The Battle Within Meta Over Chatbot SafetyFrom 🇺🇸 The Journal, published at 2025-05-27 20:00
Meta has gone all in on chatbots. The bots are capable of giving advice, answering questions and playing games with users. Some feature the licensed voices of some celebrities. But after months of testing, the Wall Street Journal found Meta's chatbots were also capable of engaging in graphic romantic roleplay, even with young users. Some people inside the company are concerned. Jeff Horwitz reports and Kate Linebaugh hosts for the last time. Further Listening: - Does Meta Have a Social Media Monopoly? - The Facebook Files Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Readers Can’t Get Enough of BookTok. Publishers Are Cashing In.From 🇺🇸 The Journal, published at 2025-05-26 16:00
We're off for Memorial Day but with summer reading season just beginning, we wanted to share this episode.BookTok, the corner of TikTok that’s all about books, has shaken up the publishing world. Over the last few years, the platform has pulled in new readers, especially in the romance and fantasy genres. And now some of the largest publishers in the U.S. are finding new talent and rethinking their strategies because of TikTok. We hear from an author, a bookstore owner and a publisher about how TikTok has transformed the book industry. Jessica Mendoza hosts.This episode was first published in December 2024. Further Listening: -The Rise of the Tween Shopper -Inside One Publisher’s Fight Against Book Bans -Scholastic's Succession Drama Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Lady Gaga, Low-Rise Jeans, and the Next RecessionFrom 🇺🇸 The Journal, published at 2025-05-23 20:20
Economists have long analyzed data to predict the next recession. They’ve also turned to more offbeat economic gauges like underwear sales and skirt lengths. But now, the TikTok generation is seeing recession indicators everywhere. WSJ’s Hannah Erin Lang explains what Gen Z’s fascination with harbingers of economic doom might actually mean for the economy. Jessica Mendoza hosts. Further Listening: - Is the Economy… OK? - Trump 2.0: Where Is The Economy Headed? Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Eggs Are Still Expensive. Is This Company to Blame?From 🇺🇸 The Journal, published at 2025-05-22 20:00
Some consumers and lawmakers upset over high egg prices believe they’ve found a villain: Cal-Maine. The little-known company produces one out of every five eggs sold in the U.S. And in the midst of a national egg shortage and a bird flu epidemic, Cal-Maine has been raking in the profits. But are the accusations against Cal-Maine fair? WSJ’s Patrick Thomas investigates. Annie Minoff hosts. Further Listening: -An Eggspensive Dilemma -Bird Flu and the High Price of Eggs Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?From 🇺🇸 The Journal, published at 2025-05-21 20:00
Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica Mendoza hosts. Further Listening: Trillion Dollar Shot Why WeightWatchers Wants in on Drugs Like Ozempic Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices